Prime Medicine
$2.97
177
+$0.02+0.68% Friday 20:00
Statistics
Day High
3.1
Day Low
2.92
52W High
6.67
52W Low
1.17
Volume
2,272,200
Avg. Volume
-
Mkt Cap
536.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Sep 19
$0.8
Jun 19
$0.2
Dec 18
$0.21
Sep 18
$0.23
Jun 18
$0.15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
6AugExpected
Expected EPS
-0.255122
Actual EPS
N/A
Financials
-6,566.61%Profit Margin
Unprofitable5.97MRevenue
-391.76MNet Income
Analyst Ratings
8.5Average Price Target
The highest estimate is 11.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PRME. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.86B
Editas Medicine
EDIT
Mkt Cap270.22M
Intellia Therapeutics
NTLA
Mkt Cap1.76B
Beam Therapeutics
BEAM
Mkt Cap2.95B
Sangamo Therapeutics
SGMO
Mkt Cap70.43M
Pacific Biosciences of California
PACB
Mkt Cap378.93M
Twist Bioscience
TWST
Mkt Cap3.77B
Holdings
Regions
Sectors
About
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Jeffrey D. Marrazzo M.B.A., M.P.A.
Employees
214
Country
United States
ISIN
US74168J1016
Listings
0 Comments
Share your thoughts
FAQ
What is Prime Medicine stock price today?▼
The current price of PRME is $2.97 USD — it has increased by +0.68% in the past 24 hours. Watch Prime Medicine stock price performance more closely on the chart.
What is Prime Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Prime Medicine stocks are traded under the ticker PRME.
Is Prime Medicine stock price growing?▼
PRME stock has risen by +10% compared to the previous week, the month change is a -19.73% fall, over the last year Prime Medicine has showed a +130.23% increase.
What is Prime Medicine market cap?▼
Today Prime Medicine has the market capitalization of 536.12M
When is the next Prime Medicine earnings date?▼
Prime Medicine is going to release the next earnings report on August 06, 2026.
What were Prime Medicine earnings last quarter?▼
PRME earnings for the last quarter are -0.28 USD per share, whereas the estimation was -0.25 USD resulting in a -11.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Prime Medicine revenue for the last year?▼
Prime Medicine revenue for the last year amounts to 5.97M USD.
What is Prime Medicine net income for the last year?▼
PRME net income for the last year is -391.76M USD.
Does Prime Medicine pay dividends?▼
Yes, PRME dividends are paid quarterly. The last dividend per share was 0.8 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Prime Medicine have?▼
As of May 26, 2026, the company has 214 employees.
In which sector is Prime Medicine located?▼
Prime Medicine operates in the Health & Wellness sector.
When did Prime Medicine complete a stock split?▼
Prime Medicine has not had any recent stock splits.
Where is Prime Medicine headquartered?▼
Prime Medicine is headquartered in Cambridge, United States.